Everolimus - Rezultatele cautarii

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

everolimus tad 5 mg tablets

tad pharma gmbh - everolimus - tablet - 5 milligram(s) - protein kinase inhibitors; everolimus

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

everolimus tad 10 mg tablets

tad pharma gmbh - everolimus - tablet - 10 milligram(s) - protein kinase inhibitors; everolimus

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

afinitor- everolimus tablet afinitor disperz- everolimus tablet, for suspension

novartis pharmaceuticals corporation - everolimus (unii: 9hw64q8g6g) (everolimus - unii:9hw64q8g6g) - everolimus 5 mg - afinitor® is indicated for the treatment of postmenopausal women with advanced hormone receptor-positive, her2-negative breast cancer in combination with exemestane, after failure of treatment with letrozole or anastrozole. afinitor is indicated for the treatment of adult patients with progressive neuroendocrine tumors of pancreatic origin (pnet) with unresectable, locally advanced or metastatic disease. afinitor is indicated for the treatment of adult patients with progressive, well-differentiated, non-functional net of gastrointestinal (gi) or lung origin with unresectable, locally advanced or metastatic disease. limitations of use: afinitor is not indicated for the treatment of patients with functional carcinoid tumors [see clinical studies (14.2)] . afinitor is indicated for the treatment of adult patients with advanced rcc after failure of treatment with sunitinib or sorafenib. afinitor is indicated for the treatment of adult patients with renal angiomyolipoma and tsc, not requiring immediate surgery.

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

everolimus teva 5 mg tablets

teva b.v. - everolimus - tablet - 5 milligram(s) - protein kinase inhibitors; imatinib

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

everolimus teva 10 mg tablets

teva b.v. - everolimus - tablet - 10 milligram(s) - protein kinase inhibitors; imatinib